Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rujia Zheng

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Biometrics|March 19, 2026
A robust covariate-balancing method for estimating individualized treatment with censored dataRujia Zheng, Wensheng Zhu, Xiaofan Guo
Chinese Clinical Oncology|July 9, 2026
Network pharmacology of Sijunzi decoction in pancreatic cancerRujia Zheng, Qitai Chen, Mengting Zhang, et al.
Chinese Clinical Oncology|June 11, 2026
Network pharmacology of Sijunzi decoction in pancreatic cancerRujia Zheng, Qitai Chen, Mengting Zhang, et al.
Antioxidants (Basel, Switzerland)|July 27, 2024
The Cancer Antioxidant Regulation System in Therapeutic ResistanceXuanhao Gu, Chunyang Mu, Rujia Zheng, et al.
Cancer Letters|April 1, 2026
Postoperative exosomal miR-1246 fuels hepatocellular carcinoma metastasis via BMP9-SMAD7 axis suppressionZhe Zhang, Xishan Yang, Rujia Zheng, et al.
Cell Reports|April 11, 2024
IFNα-induced BST2<sup>+</sup> tumor-associated macrophages facilitate immunosuppression and tumor growth in pancreatic cancer by ERK-CXCL7 signalingChenlei Zheng, Junli Wang, Yu Zhou, et al.
Science Translational Medicine|December 3, 2025
Metabolism-programming mRNA-lipid nanoparticles remodel the immune microenvironment to improve immunotherapy against MAFLDXinyang Yu, Shaolong Qi, Wanyue Cao, et al.
International Journal of Surgery (London, England)|August 27, 2022
Histological tumor micronecrosis in resected specimens after R0 hepatectomy for hepatocellular carcinomas is a factor in determining adjuvant TACE: A retrospective propensity score-matched studyYangyang Wang, Hongbin Ge, Manyi Hu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 3, 2025
Nano-enabled repurposing of Benproperine phosphate enhances pancreatic Cancer chemotherapy through lethal autophagy arrest and immune activationZhe Zhang, Qitai Chen, Rujia Zheng, et al.
Nature Communications|February 26, 2026
Tumor-associated CD19<sup>+</sup> macrophages induce immunosuppressive microenvironment in hepatocellular carcinomaJunli Wang, Wanyue Cao, Jinyan Huang, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Biometrics|March 19, 2026
A robust covariate-balancing method for estimating individualized treatment with censored dataRujia Zheng, Wensheng Zhu, Xiaofan Guo
Chinese Clinical Oncology|July 9, 2026
Network pharmacology of Sijunzi decoction in pancreatic cancerRujia Zheng, Qitai Chen, Mengting Zhang, et al.
Chinese Clinical Oncology|June 11, 2026
Network pharmacology of Sijunzi decoction in pancreatic cancerRujia Zheng, Qitai Chen, Mengting Zhang, et al.
Antioxidants (Basel, Switzerland)|July 27, 2024
The Cancer Antioxidant Regulation System in Therapeutic ResistanceXuanhao Gu, Chunyang Mu, Rujia Zheng, et al.
Cancer Letters|April 1, 2026
Postoperative exosomal miR-1246 fuels hepatocellular carcinoma metastasis via BMP9-SMAD7 axis suppressionZhe Zhang, Xishan Yang, Rujia Zheng, et al.
Cell Reports|April 11, 2024
IFNα-induced BST2<sup>+</sup> tumor-associated macrophages facilitate immunosuppression and tumor growth in pancreatic cancer by ERK-CXCL7 signalingChenlei Zheng, Junli Wang, Yu Zhou, et al.
Science Translational Medicine|December 3, 2025
Metabolism-programming mRNA-lipid nanoparticles remodel the immune microenvironment to improve immunotherapy against MAFLDXinyang Yu, Shaolong Qi, Wanyue Cao, et al.
International Journal of Surgery (London, England)|August 27, 2022
Histological tumor micronecrosis in resected specimens after R0 hepatectomy for hepatocellular carcinomas is a factor in determining adjuvant TACE: A retrospective propensity score-matched studyYangyang Wang, Hongbin Ge, Manyi Hu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 3, 2025
Nano-enabled repurposing of Benproperine phosphate enhances pancreatic Cancer chemotherapy through lethal autophagy arrest and immune activationZhe Zhang, Qitai Chen, Rujia Zheng, et al.
Nature Communications|February 26, 2026
Tumor-associated CD19<sup>+</sup> macrophages induce immunosuppressive microenvironment in hepatocellular carcinomaJunli Wang, Wanyue Cao, Jinyan Huang, et al.
Pageof 2